The past few months have been very exciting for our team. Following our recent acquisition by Inova, we’ve been working hard on defining the future of Labiotech.
From our humble beginnings in France to our expansion into the European market, we’ve always been keen to explore new horizons for the benefit of our readers.
Once more, we’re pushing the boundaries of our journalism and this time, we’re going global!
We’ve always contemplated the idea of starting worldwide coverage of biotech. But up until now, we preferred to focus our attention on the European market, as it already takes a certain amount of resources to cover properly.
One of the reasons we decided to join Inova was the possibility of investing more in our editorial resources. With the recent arrival of our new Editor-in-Chief, this ambition is becoming a reality and we can’t wait to start.
Where other media are primarily focused on the North American market, we intend to be truly international and cover all continents as much as possible.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.